ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2794

Deletion of the Inhibitory Receptor Motif, ITIM, on DC-STAMP Alters Osteoclast Differentiation and Function

Yahui Grace Chiu1, Edward M. Schwarz2, Dongge Li1, Yuexin Xu3, Minsoo Kim3 and Christopher T. Ritchlin4, 1Allergy, Immunology and Rheumatology, University of Rochester, Rochester, NY, 2Center for Musculoskeletal Research, University of Rochester, Rochester, NY, 3Microbiology and Immunology, University of Rochester, Rochester, NY, 4Allergy Immunology & Rheumatology, University of Rochester Medical Center, Rochester, NY

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Calcium, cell biology, osteoclastogenesis, osteoclasts and signal transduction

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Biology and Pathology of Bone and Joint I: Bone Remodeling in Inflammation and Arthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose

DC-STAMP (Dendritic Cell-Specific Transmembrane Protein), a 7-pass transmembrane protein essential for cell-to-cell fusion during osteoclast (OC) differentiation, is expressed on the cell surface of OC precursors (OCP). DC-STAMP knock-out (KO) mice form only mononuclear OC and have mild osteopetrosis due to the absence of functional multi-nucleated OC with bone erosion activity. Previously, we identified an Immunoreceptor Tyrosine-based Inhibitory Motif (ITIM) on the cytoplasmic tail of DC-STAMP, which suggested the potential role of DC-STAMP in signaling during osteoclastogenesis. A major hurdle in DC-STAMP research, however, is the absence of a known ligand. To overcome this barrier, we engineered DC-STAMP:Rhodopisn chimeric molecules that can be activated by light (photo-activatable). This approach enabled us to investigate the downstream events of DC-STAMP activation, and examine the importance and function of the ITIM in osteoclastogenesis.

Methods

DNA constructs were generated in which the four extracellular domains of DC-STAMP were replaced with the photo-activatable extracellular domains of rhodopsin. The functionality of two DC-STAMP chimeras (WT: original ITIM; TD: ITIM-deleted) was confirmed by: (1) activation of a calcium signal by 505-nm light, a wavelength that specifically excites rhodopsin; and (2) expression of mCherry protein (red), which was fused to the C’-terminus of DC-STAMP during engineering. These 2 chimeras were transfected into either murine 293T cells, or mouse bone marrow-derived macrophages (BMM) isolated from the DC-STAMP KO mice. To assess the role of the ITIM in signaling, we assessed the dynamic intracellular Ca2+flux known to occur during normal osteoclastogenesis between the WT and TD transfected cells. Bone erosion was assessed by the bone wafer assay.

Results

The studies with the transfected chimeric molecules revealed the following. First, deletion of ITIM on DC-STAMP resulted in a significant and continuous (non-pulsatile) elevation (3-fold >WT DC-STAMP) in the intracellular Ca2+ level after light activation. Second, ITIM-deleted DC-STAMP did not complement the deficiency of cell-cell fusion in DC-STAMP KO cells, which was fully corrected and restored by the WT DC-STAMP. Most cells expressing ITIM-deleted DC-STAMP were unable to fuse, although rare cells with 3 nuclei were observed. Third, In contrast to an even distribution of wild-type DC-STAMP on the cell surface, ITIM-deleted DC-STAMP was expressed on the cell surface in a clustered and punctate distribution fashion. Fourth, bone resorption was decreased in cells expressing TD compared to WT DC-STAMP.

Conclusion

Our results suggest that the ITIM on the cytoplasmic tail of DC-STAMP functions (1) to induce pulsatile intracellular Ca2+ flux required for osteoclastogenesis after DC-STAMP activation; (2) to trigger cell-to-cell fusion between OCPs and form multinucleated mature OC; (3) to maintain an even distribution of DC-STAMP on the cell surface; (4) to support bone erosion activity of OC. Blocking the ITIM on DC-STAMP by targeted inhibition might serve as a novel strategy to inhibit pathologic bone resorption by OC in inflammatory and metabolic bone disorders.


Disclosure:

Y. G. Chiu,
None;

E. M. Schwarz,

Johnson & Johnson,

5,

NIAMS-NIH,

2;

D. Li,
None;

Y. Xu,
None;

M. Kim,
None;

C. T. Ritchlin,

Eli Lilly and Company,

9,

Eli Lilly and Company,

5.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/deletion-of-the-inhibitory-receptor-motif-itim-on-dc-stamp-alters-osteoclast-differentiation-and-function/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology